Clinic
Contra Costa County
Contra Costa County was paid $83.05M by Medicaid between Jan 2018 and Dec 2024, across 185 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 81% of everything it billed.
33Billing provider infoCONTRA COSTA COUNTY
CONCORD, CA 94519
CONCORD, CA 94519
33aNPI1346328507assigned 11/02/2006
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$83.05M
24GClaims1,086,143
24DCodes billed185
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in California
Rank by total paid#36 of 826
Median peer was paid$4.05M
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LEE, DAVID controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 96,610 | $13.93M | |
| 2019 | 98,831 | $10.74M | |
| 2020 | 139,386 | $10.64M | |
| 2021 | 226,055 | $13.66M | |
| 2022 | 178,616 | $10.99M | |
| 2023 | 169,897 | $11.78M | |
| 2024incomplete | 176,748 | $11.30M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 81% | 197,143 | 176,811 | $67.65M |
| 0510 | 15% | 148,998 | 138,274 | $12.13M | |
| 00003 | Internal/system code - not a standard HCPCS code | 2.0% | 3,962 | 3,344 | $1.70M |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | <1% | 2,388 | 2,212 | $459K |
| 0002A | <1% | 6,847 | 5,909 | $193K | |
| 0001A | <1% | 7,013 | 5,987 | $193K | |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | <1% | 3,449 | 815 | $88K |
| 0054A | <1% | 1,776 | 1,773 | $72K | |
| 0004A | <1% | 1,901 | 1,900 | $71K | |
| 99078 | <1% | 1,812 | 688 | $70K | |
| 0011A | <1% | 1,973 | 1,528 | $60K | |
| 0124A | <1% | 1,299 | 1,262 | $56K |
173 more codes
| 0012A | <1% | 1,805 | $55K | |
| 0071A | <1% | 1,438 | $50K | |
| 0064A | <1% | 1,139 | $45K | |
| 91322 | <1% | 210 | $25K | |
| 0031A | <1% | 552 | $21K | |
| 0134A | <1% | 274 | $12K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 6,674 | $11K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 430 | $10K |
| 90480 | <1% | 296 | $9K | |
| 0052A | <1% | 229 | $9K | |
| 0072A | <1% | 191 | $8K | |
| 0051A | <1% | 160 | $6K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 123,242 | $6K |
| 0003A | <1% | 146 | $5K | |
| 0074A | <1% | 76 | $5K | |
| 0081A | <1% | 56 | $4K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 19,942 | $3K |
| 0154A | <1% | 46 | $2K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 54 | $2K |
| Z7500 | <1% | 97,041 | $2K | |
| 0082A | <1% | 30 | $2K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 58 | $2K |
| 0111A | <1% | 19 | $1K | |
| 0013A | <1% | 36 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,595 | $1K |
| 0112A | <1% | 13 | $871.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 19,543 | $709.01 |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 41,193 | $612.28 |
| 36415 | Collection of venous blood by venipuncture | <1% | 29,693 | $294.70 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,834 | $228.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 15,629 | $192.00 |
| 85027 | <1% | 5,990 | $167.00 | |
| 80061 | Lipid panel | <1% | 3,269 | $124.20 |
| Q3014 | Telehealth originating site facility fee | <1% | 71,362 | $121.14 |
| 99205 | Prolong outpt/office vis | <1% | 4,291 | $121.03 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 873 | $18.60 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 7,439 | $17.85 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 34,487 | $12.00 |
| 84460 | 0% | 1,510 | $0.00 | |
| 84466 | 0% | 606 | $0.00 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 0% | 53,978 | $0.00 |
| 83721 | 0% | 2,224 | $0.00 | |
| 97810 | 0% | 2,656 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 339 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 570 | $0.00 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 9,647 | $0.00 |
| 90633 | 0% | 3,317 | $0.00 | |
| Z6500 | 0% | 67 | $0.00 | |
| 90658 | 0% | 574 | $0.00 | |
| 81002 | 0% | 4,430 | $0.00 | |
| 82465 | 0% | 545 | $0.00 | |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 2,762 | $0.00 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 7,235 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 2,581 | $0.00 |
| 90715 | 0% | 2,558 | $0.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 31 | $0.00 |
| 90670 | 0% | 3,178 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 2,284 | $0.00 |
| 83540 | 0% | 658 | $0.00 | |
| 90750 | 0% | 1,744 | $0.00 | |
| 83718 | 0% | 572 | $0.00 | |
| 90649 | 0% | 2,721 | $0.00 | |
| 82947 | 0% | 1,130 | $0.00 | |
| 99173 | 0% | 363 | $0.00 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 9,359 | $0.00 |
| 80076 | 0% | 174 | $0.00 | |
| 86900 | 0% | 411 | $0.00 | |
| 99188 | 0% | 2,038 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 929 | $0.00 |
| 83655 | 0% | 836 | $0.00 | |
| 86787 | 0% | 117 | $0.00 | |
| Z6202 | 0% | 132 | $0.00 | |
| Z6304 | 0% | 504 | $0.00 | |
| 59425 | 0% | 569 | $0.00 | |
| 84450 | 0% | 543 | $0.00 | |
| 90700 | 0% | 155 | $0.00 | |
| 81003 | 0% | 50 | $0.00 | |
| 86480 | 0% | 215 | $0.00 | |
| 90671 | 0% | 401 | $0.00 | |
| 82565 | 0% | 51 | $0.00 | |
| 90662 | 0% | 143 | $0.00 | |
| 84439 | 0% | 95 | $0.00 | |
| Z6300 | 0% | 86 | $0.00 | |
| Z6400 | 0% | 277 | $0.00 | |
| 0272 | 0% | 160 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 35 | $0.00 |
| 84520 | 0% | 49 | $0.00 | |
| 82570 | 0% | 171 | $0.00 | |
| 90707 | 0% | 99 | $0.00 | |
| 83020 | 0% | 13 | $0.00 | |
| 90734 | 0% | 86 | $0.00 | |
| 87338 | 0% | 97 | $0.00 | |
| Z6302 | 0% | 27 | $0.00 | |
| 86708 | 0% | 15 | $0.00 | |
| 90710 | 0% | 341 | $0.00 | |
| 85014 | 0% | 13 | $0.00 | |
| 90713 | 0% | 52 | $0.00 | |
| 90648 | 0% | 44 | $0.00 | |
| S4993 | Contraceptive pills for birth control | 0% | 14 | $0.00 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 96 | $0.00 |
| 82274 | 0% | 26 | $0.00 | |
| 86038 | 0% | 29 | $0.00 | |
| 83013 | 0% | 13 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 15 | $0.00 |
| Z6308 | 0% | 14 | $0.00 | |
| 90686 | 0% | 28,540 | $0.00 | |
| 90677 | 0% | 2,004 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 3,809 | $0.00 |
| Z1034 | 0% | 7,853 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 4,132 | $0.00 |
| 90656 | 0% | 4,617 | $0.00 | |
| 87625 | 0% | 112 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 306 | $0.00 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 988 | $0.00 |
| 90739 | 0% | 3,992 | $0.00 | |
| 88142 | 0% | 776 | $0.00 | |
| 86901 | 0% | 411 | $0.00 | |
| 82784 | 0% | 55 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 1,911 | $0.00 |
| 0271 | 0% | 631 | $0.00 | |
| 90651 | 0% | 513 | $0.00 | |
| Z7610 | 0% | 2,062 | $0.00 | |
| D1310 | 0% | 809 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 1,122 | $0.00 |
| 86592 | 0% | 162 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 982 | $0.00 |
| Z1038 | 0% | 16 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 2,533 | $0.00 |
| 86850 | 0% | 411 | $0.00 | |
| 90680 | 0% | 1,785 | $0.00 | |
| 85018 | 0% | 357 | $0.00 | |
| 90697 | 0% | 1,375 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 972 | $0.00 |
| D1208 | Topical application of fluoride, excluding varnish | 0% | 846 | $0.00 |
| Z1032 | 0% | 458 | $0.00 | |
| 90647 | 0% | 802 | $0.00 | |
| 86803 | 0% | 470 | $0.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 1,049 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 2,847 | $0.00 |
| 82607 | 0% | 666 | $0.00 | |
| 87081 | 0% | 569 | $0.00 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 545 | $0.00 |
| 90619 | 0% | 827 | $0.00 | |
| 90716 | 0% | 271 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 318 | $0.00 |
| V5008 | Hearing screening | 0% | 375 | $0.00 |
| 90696 | 0% | 240 | $0.00 | |
| 90674 | 0% | 94 | $0.00 | |
| 86481 | 0% | 66 | $0.00 | |
| 86762 | 0% | 136 | $0.00 | |
| 86141 | 0% | 60 | $0.00 | |
| 90723 | 0% | 440 | $0.00 | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 0% | 85 | $0.00 |
| 87340 | 0% | 54 | $0.00 | |
| 88720 | 0% | 652 | $0.00 | |
| 82728 | 0% | 684 | $0.00 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 0% | 241 | $0.00 |
| 90688 | 0% | 425 | $0.00 | |
| Z6404 | 0% | 28 | $0.00 | |
| 85652 | 0% | 92 | $0.00 | |
| 86364 | 0% | 55 | $0.00 | |
| Z6406 | 0% | 152 | $0.00 | |
| 82043 | 0% | 129 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 166 | $0.00 |
| Z6402 | 0% | 26 | $0.00 | |
| 82950 | 0% | 37 | $0.00 | |
| 0636 | 0% | 29 | $0.00 | |
| 90620 | 0% | 170 | $0.00 | |
| 84132 | 0% | 39 | $0.00 | |
| 86704 | 0% | 12 | $0.00 | |
| 99383 | 0% | 17 | $0.00 | |
| 86706 | 0% | 13 | $0.00 | |
| 90744 | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEE, DAVID (DEPUTY CFO)
Parent organizationCONTRA COSTA COUNTY
| Provider | Location | Paid |
|---|---|---|
| Contra Costa County | Martinez, CA | $536.98M |
| Contra Costa County | Pittsburg, CA | $202.20M |
| Contra Costa County | San Pablo, CA | $170.81M |
| Contra Costa County | Martinez, CA | $100.64M |
| Contra Costa County | Martinez, CA | $90.59M |
| Contra Costa County | Antioch, CA | $65.79M |
| Contra Costa County | Martinez, CA | $64.10M |
| Contra Costa County | Brentwood, CA | $45.11M |
| Contra Costa County | Concord, CA | $33.14M |
| Lone Star Ambulance 1, LLC | Corpus Christi, TX | $31.57M |
| Contra Costa County | Martinez, CA | $30.20M |
| Contra Costa County | San Pablo, CA | $28.69M |
| Contra Costa County | Pittsburg, CA | $24.26M |
| Contra Costa County | Concord, CA | $19.55M |
| Contra Costa County | Antioch, CA | $17.16M |
| Contra Costa County | Martinez, CA | $15.98M |
| Contra Costa County | North Richmond, CA | $14.20M |
| Contra Costa County | San Pablo, CA | $13.26M |
| Contra Costa County | Bay Point, CA | $10.44M |
| Contra Costa County | Martinez, CA | $7.24M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.